vs

Side-by-side financial comparison of Citizens Community Bancorp Inc. (CZWI) and NEKTAR THERAPEUTICS (NKTR). Click either name above to swap in a different company.

NEKTAR THERAPEUTICS is the larger business by last-quarter revenue ($21.8M vs $15.8M, roughly 1.4× Citizens Community Bancorp Inc.). Citizens Community Bancorp Inc. runs the higher net margin — 27.1% vs -165.4%, a 192.6% gap on every dollar of revenue. On growth, Citizens Community Bancorp Inc. posted the faster year-over-year revenue change (14.9% vs -25.3%). Citizens Community Bancorp Inc. produced more free cash flow last quarter ($10.4M vs $-65.0M). Over the past eight quarters, Citizens Community Bancorp Inc.'s revenue compounded faster (1.9% CAGR vs 0.4%).

Glacier Bancorp, Inc. is a regional multi-bank holding company headquartered in Kalispell, Montana, United States. It is a successor corporation to the Delaware corporation originally incorporated in 1990. The company provides personal and commercial banking services from 221 locations in Montana, Idaho, Utah, Washington, Wyoming, Colorado, Arizona, and, Nevada.

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, e...

CZWI vs NKTR — Head-to-Head

Bigger by revenue
NKTR
NKTR
1.4× larger
NKTR
$21.8M
$15.8M
CZWI
Growing faster (revenue YoY)
CZWI
CZWI
+40.1% gap
CZWI
14.9%
-25.3%
NKTR
Higher net margin
CZWI
CZWI
192.6% more per $
CZWI
27.1%
-165.4%
NKTR
More free cash flow
CZWI
CZWI
$75.4M more FCF
CZWI
$10.4M
$-65.0M
NKTR
Faster 2-yr revenue CAGR
CZWI
CZWI
Annualised
CZWI
1.9%
0.4%
NKTR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CZWI
CZWI
NKTR
NKTR
Revenue
$15.8M
$21.8M
Net Profit
$4.3M
$-36.1M
Gross Margin
Operating Margin
31.0%
-126.9%
Net Margin
27.1%
-165.4%
Revenue YoY
14.9%
-25.3%
Net Profit YoY
58.1%
-596.9%
EPS (diluted)
$0.44
$-4.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CZWI
CZWI
NKTR
NKTR
Q4 25
$15.8M
$21.8M
Q3 25
$16.2M
$11.8M
Q2 25
$16.1M
$11.2M
Q1 25
$14.2M
$10.5M
Q4 24
$13.7M
$29.2M
Q3 24
$14.2M
$24.1M
Q2 24
$13.5M
$23.5M
Q1 24
$15.2M
$21.6M
Net Profit
CZWI
CZWI
NKTR
NKTR
Q4 25
$4.3M
$-36.1M
Q3 25
$3.7M
$-35.5M
Q2 25
$3.3M
$-41.6M
Q1 25
$3.2M
$-50.9M
Q4 24
$2.7M
$7.3M
Q3 24
$3.3M
$-37.1M
Q2 24
$3.7M
$-52.4M
Q1 24
$4.1M
$-36.8M
Gross Margin
CZWI
CZWI
NKTR
NKTR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
72.7%
Q3 24
81.6%
Q2 24
58.5%
Q1 24
60.6%
Operating Margin
CZWI
CZWI
NKTR
NKTR
Q4 25
31.0%
-126.9%
Q3 25
27.9%
-268.6%
Q2 25
25.1%
-324.2%
Q1 25
28.0%
-425.8%
Q4 24
24.5%
49.2%
Q3 24
29.5%
-142.4%
Q2 24
35.0%
-211.9%
Q1 24
34.2%
-163.7%
Net Margin
CZWI
CZWI
NKTR
NKTR
Q4 25
27.1%
-165.4%
Q3 25
22.7%
-301.3%
Q2 25
20.3%
-372.2%
Q1 25
22.5%
-486.4%
Q4 24
19.7%
24.9%
Q3 24
23.1%
-153.6%
Q2 24
27.2%
-222.9%
Q1 24
26.9%
-170.1%
EPS (diluted)
CZWI
CZWI
NKTR
NKTR
Q4 25
$0.44
$-4.67
Q3 25
$0.37
$-1.87
Q2 25
$0.33
$-2.95
Q1 25
$0.32
$-0.24
Q4 24
$0.28
$-2.07
Q3 24
$0.32
$-2.66
Q2 24
$0.35
$-3.76
Q1 24
$0.39
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CZWI
CZWI
NKTR
NKTR
Cash + ST InvestmentsLiquidity on hand
$118.9M
$15.1M
Total DebtLower is stronger
$51.8M
Stockholders' EquityBook value
$187.9M
$89.8M
Total Assets
$1.8B
$280.4M
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CZWI
CZWI
NKTR
NKTR
Q4 25
$118.9M
$15.1M
Q3 25
$82.4M
$41.0M
Q2 25
$67.5M
$43.0M
Q1 25
$100.2M
$38.9M
Q4 24
$50.2M
$44.3M
Q3 24
$36.6M
$30.1M
Q2 24
$36.9M
$27.9M
Q1 24
$28.6M
$48.6M
Total Debt
CZWI
CZWI
NKTR
NKTR
Q4 25
$51.8M
Q3 25
Q2 25
Q1 25
Q4 24
$66.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CZWI
CZWI
NKTR
NKTR
Q4 25
$187.9M
$89.8M
Q3 25
$186.8M
$85.1M
Q2 25
$183.5M
$-24.2M
Q1 25
$180.1M
$13.7M
Q4 24
$179.1M
$60.7M
Q3 24
$180.1M
$48.9M
Q2 24
$176.0M
$79.7M
Q1 24
$172.8M
$126.7M
Total Assets
CZWI
CZWI
NKTR
NKTR
Q4 25
$1.8B
$280.4M
Q3 25
$1.7B
$301.3M
Q2 25
$1.7B
$207.5M
Q1 25
$1.8B
$256.2M
Q4 24
$1.7B
$303.9M
Q3 24
$1.8B
$308.0M
Q2 24
$1.8B
$343.3M
Q1 24
$1.8B
$396.0M
Debt / Equity
CZWI
CZWI
NKTR
NKTR
Q4 25
0.28×
Q3 25
Q2 25
Q1 25
Q4 24
0.37×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CZWI
CZWI
NKTR
NKTR
Operating Cash FlowLast quarter
$11.7M
$-65.0M
Free Cash FlowOCF − Capex
$10.4M
$-65.0M
FCF MarginFCF / Revenue
65.9%
-298.0%
Capex IntensityCapex / Revenue
8.3%
0.1%
Cash ConversionOCF / Net Profit
2.74×
TTM Free Cash FlowTrailing 4 quarters
$17.5M
$-208.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CZWI
CZWI
NKTR
NKTR
Q4 25
$11.7M
$-65.0M
Q3 25
$6.6M
$-48.8M
Q2 25
$-406.0K
$-45.7M
Q1 25
$1.6M
$-49.1M
Q4 24
$20.4M
$-46.2M
Q3 24
$3.5M
$-43.9M
Q2 24
$5.1M
$-37.7M
Q1 24
$9.1M
$-47.9M
Free Cash Flow
CZWI
CZWI
NKTR
NKTR
Q4 25
$10.4M
$-65.0M
Q3 25
$6.2M
$-48.9M
Q2 25
$-632.0K
$-45.8M
Q1 25
$1.5M
$-49.1M
Q4 24
$19.5M
$-46.6M
Q3 24
$3.4M
$-44.6M
Q2 24
$4.8M
$-37.9M
Q1 24
$8.9M
$-48.0M
FCF Margin
CZWI
CZWI
NKTR
NKTR
Q4 25
65.9%
-298.0%
Q3 25
38.4%
-414.5%
Q2 25
-3.9%
-409.6%
Q1 25
10.7%
-469.0%
Q4 24
142.2%
-159.9%
Q3 24
23.8%
-184.9%
Q2 24
35.7%
-161.3%
Q1 24
58.9%
-222.0%
Capex Intensity
CZWI
CZWI
NKTR
NKTR
Q4 25
8.3%
0.1%
Q3 25
2.4%
1.0%
Q2 25
1.4%
0.3%
Q1 25
0.7%
0.0%
Q4 24
6.5%
1.6%
Q3 24
0.9%
2.8%
Q2 24
2.3%
0.8%
Q1 24
1.4%
0.7%
Cash Conversion
CZWI
CZWI
NKTR
NKTR
Q4 25
2.74×
Q3 25
1.80×
Q2 25
-0.12×
Q1 25
0.50×
Q4 24
7.55×
-6.36×
Q3 24
1.07×
Q2 24
1.39×
Q1 24
2.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons